Congrats to the PeptAI team on being selected for Track 2 of the @adaptyvbio x @AnthropicAI Protein Design Competition! Great to see the team joining researchers from around the world to advance AI-driven protein design and put new designs to the test. Follow @peptai_ to track their progress ↓

Finding the right open source scientific software shouldn't be the hard part of your research. Open Science Index groups tools by scientific application. You start from your research problem and compare the options against each other. We check the source registries daily, so you can see what is new and what is still maintained ↓

An early experiment should clarify a decision: continue, change course, or stop. A negative result can save months of work. The hard part is funding that test before there’s a success story. Bio helps research teams raise community backing for the next milestone.

Launchpad wallets can now be funded by credit card. Previously, funding a wallet meant buying elsewhere and transferring in. Card funding happens on the Launchpad itself, through @privy_io, and self-custody is unchanged: the wallet stays yours, and Bio never holds the funds. This is the first step toward something larger. Most people who want to fund science don't hold crypto and shouldn't have to. We're building the rails that let fiat capital reach research directly, and removing each piece of friction between wanting to back a project and doing it.

DeSci it is 🧬

🫡

New on OpenLabs: Synthetic TME for Cancer Therapeutics Discovery by @dominikus_brian The project is exploring how to build models of the tumour microenvironment, the cells and conditions surrounding a tumour, for cancer research. What is the smallest model that can help answer a specific question about a potential therapy? The discussion focuses on: • Which components are essential, from immune and stromal cells to oxygen levels? • How should models be tested against patient samples and clinical data? The work is at the research-planning stage, with model design and benchmarking questions open for input. Explore the project and join the discussion ↓

A virtual biotech company with tens of thousands of AI scientists. A glimpse of how research could be organized: researchers set the direction, specialist agents work through the evidence and suggest what to test in the lab. We’d like to see more researchers get a chance to put their ideas to the test.

Sometimes founders who i talk with think that raising money from our community is an easy ride, it is not. Founders need to do three things to be successful with us. 1. Build in public. Posting daily on X and soon on openlabs, and the content must be high-quality, no AI slop. 2. Make sure the content is understandable by anyone without a scientific background. 3. Keep posting and pushing updates after the raise. The raise is just the beginning. @anagenxyz in our ecosystem posts two to three times a day If you are interested in building in public and getting funding from a community you build, my DMs are open

🤝

Try Open Science Index for your next analysis: index.bio.xyz/?utm_source=X&…

The next Ignition Sale is live on Bio! @NootropicsDAO_ is building NeuroLab AI to predict how compounds could affect the brain, connecting molecular interactions to potential effects on cognition. The goal: help researchers choose which compounds to test next. Secure your NDT allocation on Bio: app.bio.xyz/agents/neurolab-…

“Science is really the engine of progress for civilization but that engine is kind of stalled a little bit. What we really need is open and permissionless science.” Science should be open to anyone who wants to help move it forward. That’s the idea behind Bio: open research networks where scientists steer AI agents, share evidence others can build on, and work with communities to fund and develop the science they care about.

Participate in the NDT sale with USDC & optionally BioXP. No BioXP? Earn it through staking BIO or ecosystem tokens. Or mint it instantly by spending BIO. Join the NDT Ignition Sale: app.bio.xyz/agents/neurolab-…

Launch details The NDT sale runs for 2 weeks. To qualify for an allocation, pledge USDC and optionally BioXP to the sale. The sale is not “first come, first served,” so as long as you pledge during the two-week window, you’ll be eligible for an allocation. • Initial Raise: $200K • Starting FDV: $3M • Initial Project Funding: $100K • Participant Vesting: 100% unlocked at claim with no cliff, no linear vest • BIO stakers (veBIO holders): 20% allocated with a 6-month linear vesting claimable at any time. At the time of claim, any tokens that have not yet vested are forfeited, with 20% vested at TGE • 6.67% allocated to the Ignition Sale

Roadmap Q4 2026 targets: • Atlas: Free user tier with 50 datasets and interactive knowledge graph exploration • Axon: APIs, access for AI agents and third-party tool integrations • Frontier: Expanded predictions for novel compounds and peptides Q1 2027 targets: • Workbench: Personal research libraries, compound comparisons and hypothesis drafting • Cortex: Deeper causal reasoning and whole-brain mapping • Commons: Community compound submissions, prioritisation voting and shared IP terms for novel candidates

Project details: NeuroLab AI by @NootropicsDAO_ Understanding a compound’s effects means connecting evidence across receptors, cells, brain circuits and cognition. NeuroLab AI is designed to trace those connections, linking each step to supporting research so researchers can inspect the evidence behind a prediction. Its biomedical knowledge graph includes: • 150,000+ nodes • Over 8 million connections • Coverage across 400+ brain regions The aim: turn scattered evidence into testable hypotheses.

Our tech team is finalizing the sale in the backend. The sale is expected to go live within the next hour. We'll share an announcement.